We recently compiled a list of the 10 Best Non-Tech Stocks to Buy Now for Long Term. In this article, we are going to take a ...
Johnson & Johnson announced data from the Phase 3 ASTRO study of TREMFYA subcutaneous, SC, induction therapy in adults with moderately to ...
Johnson & Johnson MedTech, the global leader in heart recovery, is proud to celebrate the inaugural National Heart Recovery ...
Johnson & Johnson (JNJ) closed the latest trading day at $157.89, indicating a +1.87% change from the previous session's end. This move outpaced the S&P 500's daily gain of 0.24%. At the same time, ...